4//SEC Filing
BAUER JOHN H 4
Accession 0000891293-10-000017
CIK 0000891293other
Filed
Jul 13, 8:00 PM ET
Accepted
Jul 14, 7:38 PM ET
Size
5.2 KB
Accession
0000891293-10-000017
Insider Transaction Report
Form 4
BAUER JOHN H
Director
Transactions
- Award
Common Stock
2010-07-12+996,661→ 1,784,808 total
Footnotes (1)
- [F1]As disclosed by CTIC in its proxy statement filed with the SEC on April 9, 2010, in December 2009 CTIC granted a bonus opportunity to the reporting person that was payable in shares of CTIC stock upon the achievement of certain performance goals before December 31, 2011. Under applicable SEC rules, this award did not trigger a Form 4 filing obligation. CTIC has converted a portion of this bonus opportunity into an award of performance-based restricted stock. The shares reported above on this Form 4 reflect the grant of this replacement performance-based restricted stock award that is subject to the same vesting requirements and forfeiture conditions as the corresponding portion of the reporting person's December 2009 restricted stock unit award.
Documents
Issuer
CELL THERAPEUTICS INC
CIK 0000891293
Entity typeother
Related Parties
1- filerCIK 0001248055
Filing Metadata
- Form type
- 4
- Filed
- Jul 13, 8:00 PM ET
- Accepted
- Jul 14, 7:38 PM ET
- Size
- 5.2 KB